tazarotene 0.1 % Topical Gel
- RxCUI
- 313201
- RxNorm name
- tazarotene 0.1 % Topical Gel
- Display name
- tazarotene 0.1 % Topical Gel
- Full name
- tazarotene 0.1 % Topical Gel
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:14
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trilitas | TAZAROTENE | Perfero Pharma, Inc. | 1cf1faef-73b8-4ab2-a4c8-521f0bd3fc10 | 2026-05-18 | Warnings, Adverse reactions | 313201 |
| Tazorac | TAZAROTENE | Almirall, LLC | 4e4e4b81-420e-4492-8a74-80b692a80057 | 2025-11-13 | Warnings, Adverse reactions | 313201 |
| Tazarotene | TAZAROTENE | Solaris Pharma Corporation | f1c98c4a-f101-4f3c-851a-39c827415c46 | 2025-01-02 | Warnings, Adverse reactions | 313201 |
| TAZAROTENE | TAZAROTENE | Bryant Ranch Prepack | aa6fff2f-01c7-4669-be67-07cec82c768a | 2024-05-29 | Warnings, Adverse reactions | 313201 |
| TAZAROTENE | TAZAROTENE | Padagis Israel Pharmaceuticals Ltd | ffd11dee-4266-4201-9573-1e82c2d30a63 | 2024-01-01 | Warnings, Adverse reactions | 313201 |
| TAZAROTENE | TAZAROTENE | Cosette Pharmaceuticals, Inc. | 94749b8e-0d00-4257-a660-6d0fc8815fcf | 2023-11-29 | Warnings, Adverse reactions | 313201 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| aa6fff2f-01c7-4669-be67-07cec82c768a | tazarotene 0.1 % Topical Gel | PSN | 101 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20240529 |
| aa6fff2f-01c7-4669-be67-07cec82c768a | tazarotene 0.001 MG/MG Topical Gel | SCD | 101 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20240529 |
| aa6fff2f-01c7-4669-be67-07cec82c768a | tazarotene 0.1 % Topical Gel | SY | 101 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20240529 |
| 4e4e4b81-420e-4492-8a74-80b692a80057 | tazarotene 0.001 MG/MG Topical Gel | SCD | 4 | These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20251113 |
| 4e4e4b81-420e-4492-8a74-80b692a80057 | tazarotene 0.1 % Topical Gel | SY | 4 | These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20251113 |
| 4e4e4b81-420e-4492-8a74-80b692a80057 | tazarotene 0.1 % Topical Gel | PSN | 4 | These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20251113 |
| f1c98c4a-f101-4f3c-851a-39c827415c46 | tazarotene 0.001 MG/MG Topical Gel | SCD | 4 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20250102 |
| f1c98c4a-f101-4f3c-851a-39c827415c46 | tazarotene 0.1 % Topical Gel | PSN | 4 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20250102 |
| f1c98c4a-f101-4f3c-851a-39c827415c46 | tazarotene 0.1 % Topical Gel | SY | 4 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20250102 |
| ffd11dee-4266-4201-9573-1e82c2d30a63 | tazarotene 0.1 % Topical Gel | SY | 3 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20240101 |
| ffd11dee-4266-4201-9573-1e82c2d30a63 | tazarotene 0.001 MG/MG Topical Gel | SCD | 3 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20240101 |
| ffd11dee-4266-4201-9573-1e82c2d30a63 | tazarotene 0.1 % Topical Gel | PSN | 3 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997 | 20240101 |
| 94749b8e-0d00-4257-a660-6d0fc8815fcf | tazarotene 0.1 % Topical Gel | SY | 2 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.1%, for topical use Initial U.S. Approval: 1997 | 20231129 |
| 94749b8e-0d00-4257-a660-6d0fc8815fcf | tazarotene 0.001 MG/MG Topical Gel | SCD | 2 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.1%, for topical use Initial U.S. Approval: 1997 | 20231129 |
| 94749b8e-0d00-4257-a660-6d0fc8815fcf | tazarotene 0.1 % Topical Gel | PSN | 2 | These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.1%, for topical use Initial U.S. Approval: 1997 | 20231129 |